By Brad Sorensen, CFA NASDAQ: LGVN READ THE FULL LGVN RESEARCH REPORT Longeveron (NASDAQ: LGVN) is a clinical-stage biotechnology company that has positioned itself in the regenerative medicine space ...

The Washington Attorney General’s Office announced it reached a settlement with a property management company and apartment ...